Health Policy Manag.  2021 Mar;31(1):1-4. 10.4332/KJHPA.2021.31.1.1.

Overlooking the Era of Vaccine against Coronavirus Disease 2019

Affiliations
  • 1Editor-in-Chief, Health Policy and Management
  • 2Department of Preventive Medicine, School of Medicine, Ewha Womans University, Seoul, Korea

Abstract

With this as a momentum of approval Pfizer vaccine against coronavirus disease 2019 (COVID-2019), it is changed to the era of vaccine rapidly. Most countries are trying to reserve effective vaccines and inoculate vaccines into high-risk populations for achieving community immunity. I reviewed several vaccine-related issues to be confronted for moving up to the end of COVID-2019: the efficacy and effectiveness of the approved vaccines, the priorities for vaccination into target groups, side effects, and distrust towards COVID-2019 vaccines. Evidence-based decision-making in the policy process and collaboration with professional groups are the most effective strategies for driving successful vaccination policy.

Keyword

COVID-19; Post-COVID 19; Vaccine policy
Full Text Links
  • HPM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr